(Q40840298)

English

A novel human HER2-derived peptide homologous to the mouse K(d)-restricted tumor rejection antigen can induce HLA-A24-restricted cytotoxic T lymphocytes in ovarian cancer patients and healthy individuals

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

24 September 2017

A novel human HER2-derived peptide homologous to the mouse K(d)-restricted tumor rejection antigen can induce HLA-A24-restricted cytotoxic T lymphocytes in ovarian cancer patients and healthy individuals (English)

1 reference

Europe PubMed Central

24 September 2017

1 reference

based on heuristic

inferred from title

author name string

Okugawa T

1

1 reference

Europe PubMed Central

24 September 2017

Ikuta Y

2

1 reference

Europe PubMed Central

24 September 2017

Takahashi Y

3

1 reference

Europe PubMed Central

24 September 2017

Obata H

4

1 reference

Europe PubMed Central

24 September 2017

Tanida K

5

1 reference

Europe PubMed Central

24 September 2017

Watanabe M

6

1 reference

Europe PubMed Central

24 September 2017

Imai S

7

1 reference

Europe PubMed Central

24 September 2017

Furugen R

8

1 reference

Europe PubMed Central

24 September 2017

Nagata Y

9

1 reference

Europe PubMed Central

24 September 2017

Toyoda N

10

1 reference

Europe PubMed Central

24 September 2017

Shiku H

11

1 reference

Europe PubMed Central

24 September 2017

language of work or name

0 references

publication date

1 November 2000

1 reference

Europe PubMed Central

24 September 2017

European Journal of Immunology

1 reference

Europe PubMed Central

24 September 2017

30

1 reference

Europe PubMed Central

24 September 2017

3338-3346

1 reference

Europe PubMed Central

24 September 2017

11

1 reference

Europe PubMed Central

24 September 2017

From defined human tumor antigens to effective immunization?

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200011%2930%3A11%3C3338%3A%3AAID-IMMU3338%3E3.0.CO%3B2-3

21 January 2018

T cell defined tumor antigens

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200011%2930%3A11%3C3338%3A%3AAID-IMMU3338%3E3.0.CO%3B2-3

21 January 2018

Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200011%2930%3A11%3C3338%3A%3AAID-IMMU3338%3E3.0.CO%3B2-3

21 January 2018

Tyrosine kinase receptor with extensive homology to EGF receptor shares chromosomal location with neu oncogene

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200011%2930%3A11%3C3338%3A%3AAID-IMMU3338%3E3.0.CO%3B2-3

21 January 2018

DNA typing of the HLA-A gene: population study and identification of four new alleles in Japanese

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200011%2930%3A11%3C3338%3A%3AAID-IMMU3338%3E3.0.CO%3B2-3

21 January 2018

Cytotoxic T cells isolated from ovarian malignant ascites recognize a peptide derived from the HER-2/neu proto-oncogene

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200011%2930%3A11%3C3338%3A%3AAID-IMMU3338%3E3.0.CO%3B2-3

21 January 2018

Identification of an immunodominant peptide of HER-2/neu protooncogene recognized by ovarian tumor-specific cytotoxic T lymphocyte lines

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200011%2930%3A11%3C3338%3A%3AAID-IMMU3338%3E3.0.CO%3B2-3

21 January 2018

Breast and ovarian cancer-specific cytotoxic T lymphocytes recognize the same HER2/neu-derived peptide

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200011%2930%3A11%3C3338%3A%3AAID-IMMU3338%3E3.0.CO%3B2-3

21 January 2018

Identification of Her-2/Neu CTL epitopes using double transgenic mice expressing HLA-A2.1 and human CD.8.

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200011%2930%3A11%3C3338%3A%3AAID-IMMU3338%3E3.0.CO%3B2-3

21 January 2018

The multi-epitope approach for immunotherapy for cancer: identification of several CTL epitopes from various tumor-associated antigens expressed on solid epithelial tumors.

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200011%2930%3A11%3C3338%3A%3AAID-IMMU3338%3E3.0.CO%3B2-3

21 January 2018

Poor binding of a HER-2/neu epitope (GP2) to HLA-A2.1 is due to a lack of interactions with the center of the peptide

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200011%2930%3A11%3C3338%3A%3AAID-IMMU3338%3E3.0.CO%3B2-3

21 January 2018

Mutated mitogen-activated protein kinase: a tumor rejection antigen of mouse sarcoma

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200011%2930%3A11%3C3338%3A%3AAID-IMMU3338%3E3.0.CO%3B2-3

21 January 2018

The use of anti-CD3 and anti-CD28 monoclonal antibodies to clone and expand human antigen-specific T cells

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200011%2930%3A11%3C3338%3A%3AAID-IMMU3338%3E3.0.CO%3B2-3

21 January 2018

Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200011%2930%3A11%3C3338%3A%3AAID-IMMU3338%3E3.0.CO%3B2-3

21 January 2018

Amplification and overexpression of the EGF receptor and c-erbB-2 proto-oncogenes in human stomach cancer

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200011%2930%3A11%3C3338%3A%3AAID-IMMU3338%3E3.0.CO%3B2-3

21 January 2018

Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200011%2930%3A11%3C3338%3A%3AAID-IMMU3338%3E3.0.CO%3B2-3

21 January 2018

Proliferating dendritic cell progenitors in human blood

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200011%2930%3A11%3C3338%3A%3AAID-IMMU3338%3E3.0.CO%3B2-3

21 January 2018

Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200011%2930%3A11%3C3338%3A%3AAID-IMMU3338%3E3.0.CO%3B2-3

21 January 2018

Definition of a unique cell surface antigen of mouse leukemia RL male 1 by cell-mediated cytotoxicity

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200011%2930%3A11%3C3338%3A%3AAID-IMMU3338%3E3.0.CO%3B2-3

21 January 2018

Peptide motifs of HLA-A3, -A24, and -B7 molecules as determined by pool sequencing

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200011%2930%3A11%3C3338%3A%3AAID-IMMU3338%3E3.0.CO%3B2-3

21 January 2018

Oligopeptide induction of a cytotoxic T lymphocyte response to HER-2/neu proto-oncogene in vitro

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200011%2930%3A11%3C3338%3A%3AAID-IMMU3338%3E3.0.CO%3B2-3

21 January 2018

The HER2/neu-derived peptide p654-662 is a tumor-associated antigen in human pancreatic cancer recognized by cytotoxic T lymphocytes

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200011%2930%3A11%3C3338%3A%3AAID-IMMU3338%3E3.0.CO%3B2-3

21 January 2018

Identification of HER2/neu-derived peptide epitopes recognized by gastric cancer-specific cytotoxic T lymphocytes

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200011%2930%3A11%3C3338%3A%3AAID-IMMU3338%3E3.0.CO%3B2-3

21 January 2018

Expression of the p185 encoded by HER2 oncogene in normal and transformed human tissues

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200011%2930%3A11%3C3338%3A%3AAID-IMMU3338%3E3.0.CO%3B2-3

21 January 2018

HLA-B51 transgenic mice as recipients for production of polymorphic HLA-A, B-specific antibodies

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200011%2930%3A11%3C3338%3A%3AAID-IMMU3338%3E3.0.CO%3B2-3

21 January 2018

Identifiers

10.1002/1521-4141(200011)30:11<3338::AID-IMMU3338>3.0.CO;2-3

1 reference

Europe PubMed Central

24 September 2017

1 reference

Europe PubMed Central

24 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40840298&oldid=1908504195"